Completed trials

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Cancer type: Glioblastoma

Phase: I/II

Principal Investigator: Lassen Ulrik

Country: DK

Keywords: Denmark, Rigshospitalet, GBM, bevacizumab, anti-PlGF

Status: Completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01308684?term=NCT01308684&rank=1